Associations of Tissue Tumor Mutational Burden and Mutational Status With Clinical Outcomes With Pembrolizumab Plus Chemotherapy Versus Chemotherapy For Metastatic NSCLC

  1. Garassino, M.C.
  2. Gadgeel, S.
  3. Novello, S.
  4. Halmos, B.
  5. Felip, E.
  6. Speranza, G.
  7. Hui, R.
  8. Garon, E.B.
  9. Horinouchi, H.
  10. Sugawara, S.
  11. Rodriguez-Abreu, D.
  12. Reck, M.
  13. Cristescu, R.
  14. Aurora-Garg, D.
  15. Loboda, A.
  16. Lunceford, J.
  17. Kobie, J.
  18. Ayers, M.
  19. Piperdi, B.
  20. Pietanza, M.C.
  21. Paz-Ares, L.
Revue:
JTO Clinical and Research Reports

ISSN: 2666-3643

Année de publication: 2023

Volumen: 4

Número: 1

Type: Article

DOI: 10.1016/J.JTOCRR.2022.100431 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus